Page 4 - Data Driven Approach News Today

The leading hospital magazine for hospital business news and analysis for hospital and healthcare system executives.

Each of the 17 candidates has their own ideas regarding crime, homelessness, housing affordability and more. We asked all of them the same policy questions.

BioArctic: Results from lecanemab confirmatory phase 3 Clarity AD study to be presented at 15th Clinical Trials on Alzheimer's Disease (CTAD) conference - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker findings from the companys...

/PRNewswire/ -- BioArctic ABs (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the efficacy, safety and biomarker results from the Phase 3...

Jennifer Carson, Ph.D., professor of criminology and criminal justice at the UCM, has been awarded a $506,497 grant from the National Institute of Justice.

Chief information officers and other key stakeholders first need to identify the bleeding tech causing the bloat, then create a roadmap on what aspects of the tech bloat can be reduced.

Maya Rajasekharan, Senior Advisor, Strategic Program Development at the Alliance of Bioversity International and the International Center for Tropical Agriculture (CIAT), says that food is the single greatest determinant of human health and disease over the course of one's life, and yet a comprehensive understanding of the composition of what we eat remains unknown.

A scientist has developed a new data-driven mechanistic approach that predicts cell types within the tissue that will help lower drug costs and treat diseases.

Understanding existing capabilities is key to making best use of data Businesses may recognize the value that data offers them, but research shows the wrong culture and a lack of skills are holding